AI-Driven GLP-1 Scams Hijacking European Authorities
⚠️ Criminal networks are exploiting shortages of GLP-1 drugs like Ozempic, Wegovy and Mounjaro, using AI to generate convincing counterfeit websites, emails and documents that impersonate regulators and health services across Europe. They are hijacking the identities of the NHS, AEMPS, ANSM, BfArM and AIFA to market fake weight-loss products and harvest payments. Check Point Research documents the tactics, scale and public-safety implications of this rapidly evolving scam epidemic.
